Navigation Links
UCSF faculty receive $13.7M from CIRM for stem cell research
Date:8/19/2008

Five UCSF stem cell scientists have received New Faculty grants from the California Institute for Regenerative Medicine, support that will allow them to pursue lines of investigation ultimately aimed at developing treatment strategies for such conditions as cancer, heart disease, tooth regeneration, liver disease and amyotrophic lateral sclerosis.

The UCSF grants, which range from about $2 million to $3 million each, total $13.7 million and are intended to support the scientists in the critical early stages of their careers as independent investigators establishing their own laboratories and research programs. CIRM will provide salary and research support for up to five years, creating a stable environment for the faculty to build innovative and robust stem cell research programs.

"These grants are a tremendous boon to the investigators, but also to the stem cell field overall," says Arnold Kriegstein, MD, PhD, director of the UCSF Institute for Regeneration Medicine. "They will fuel the research of some of the most creative stem cell scientists in the world, allowing them to pursue the significant scientific challenges they have set for themselves."

The grants, announced today, are the latest round of research funds awarded by the Independent Citizens Oversight Committee, which oversees CIRM. The ICOC awarded $59 million in New Faculty grants to research universities throughout California.

The UCSF researchers will use the funds to explore fundamental questions about the way in which embryonic stem cells function, how they are regulated and what molecular steps lead them to specialize as specific types of mature cells, such as liver cells. In each case, they plan to use the knowledge they gain to explore cell-replacement therapies or identify potential drugs to treat diseases.

The UCSF faculty recipients, their research areas, and grant amounts are:

  • Robert Blelloch, MD, PhD He will study molecules known as small RNAs, which he hypothesizes play a key role in controlling the expression of embryonic stem cells. Understanding the mechanisms that determine and maintain the potential of stem cells will allow the medical and pharmaceutical community to improve the efficiency with which they can produce embryonic stem cell lines, as well as quality control of the resulting cells, he says. ($3,029,897 grant)

  • Ophir Klein, MD, PhD -- He will explore the molecular processes that regulate the behavior of dental stem cells in mice, with the goal of promoting tooth regeneration and craniofacial abnormalities in humans. As the signaling pathways are similar to those of the liver and other organs, his work will shed light on regeneration of these organs, as well. His ultimate goal, he says, is to help lay the groundwork for growing human teeth and help advance efforts to regenerate larger organs. ($3,075,251 grant)

  • Emmanuelle Passegu, PhD -- She will study mouse blood stem cells to investigate how they thrive and, at times, accumulate damage that leads to cancer. Her goal is to identify molecular targets for preventing therapy-related organ damage or secondary cancers. She also will use her mouse model of human leukemia to study what molecular changes lead to cancer stem cell formation and function during disease development. The goal of this work would be to design novel therapies that target cancer stem cells while sparing normal stem cells. ($2,274,368 grant)

  • Jeremy Reiter, MD, PhD -- He will study the genes that contribute to the development of ALS and other forms of neurodegenerative motor diseases. Using a mouse model he developed, his team will examine the impact of mutant genes associated with the diseases on mouse embryonic stem cells, in order to identify the way in which they actually kill the cells. Diseased motor neurons grown in cell culture dishes could be quickly and efficiently screened with potential drugs to discover agents that slow, halt or reverse the cellular damage, he notes. ($2,259,092 grant)

  • Holger Willenbring, MD -- He will investigate the genes that establish the function of early-stage liver cells. His goal is to use this knowledge to prompt human embryonic stem cells to specialize as early-stage liver cells in the culture dish. If he succeeds, he'll transplant the cells into a mouse model of human liver disease. This would be proof of principle for the potential of embryonic stem cells for liver cell therapy, he says. ($3,032,510 grant)


'/>"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Related medicine news :

1. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
2. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
3. Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award
4. UNC faculty and students to develop plan to get clean water in poorer homes
5. UNT Health Science Center Appoints Eight New Faculty Members
6. Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award
7. Einstein honors Dr. Stanley Nathenson with Marshall S. Horwitz Faculty Prize for Research Excellence
8. AACN Concerned That the Presidents FY 2009 Budget Request Will Prolong the Nursing and Nurse Faculty Shortage
9. First Group of Minority Nurse Faculty Scholars Selected by the Johnson & Johnson Campaign for Nursings Future and AACN
10. APIC selected as faculty in Blue Shield of California Foundation initiative to fight HAIs
11. APIC Selected as Faculty in Blue Shield of California Foundation Initiative to Fight Healthcare-Associated Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... Today Omega Institute, a leading destination ... innovative workshops and training opportunities in the growing field of yoga therapy ... who are dealing with specific health issues—including injuries, illnesses, and temporary or chronic health ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit (GWS) today announced that ... offerings of Europe, a continent that pioneered the medical/wellness concept for the world. , ... in medical wellness, including Henri Chenot, Founder of the Chenot Group, which operates wellness ...
(Date:5/25/2016)... Harrisburg, PA (PRWEB) , ... May 25, 2016 ... ... today announced the results of its annual Medical and Prescription Drug survey ... health benefits. , The survey, which was conducted in December 2015, indicates ...
(Date:5/25/2016)... ... May 25, 2016 , ... Laser Skin & ... turn back the hands of time of female aging. The Juliet™ ... Women with symptoms such as leakage, laxity, itchiness and pain have reported real relief ...
(Date:5/25/2016)... ... 25, 2016 , ... Consumer access to organic foods and grower access to ... of whole grain cereals and other plant-based foods, will introduce the first consumer product ... wheat processed by Hesco/Dakota Organic Products. , The transitional designation means the cereal was ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 The innovator ... , s first dual therapy stent, introduces ... OrbusNeich, a global company specializing in the ... to include products to treat peripheral artery disease. The ... entry devices for lower limb and arteriovenous (AV) fistula ...
(Date:5/24/2016)... , May 24, 2016 Een ... verbindt, zodat zij collectief patiënten kunnen behandelen, hun kennis ... het idee achter de nieuwe en revolutionaire MDLinking App, ... de Nederlandse vaatchirurg dr. Hans Flu en oncologisch chirurg ... die inmiddels beschikbaar is, wordt op dinsdag 24 mei ...
(Date:5/23/2016)... , May 23, 2016 ... Market Size, Share, Development, Growth and Demand Forecast ... Single and Other), by Application (Drug Discovery and ... End Users (Pharmaceuticals, Life Science and Biotechnology, Academic ... P&S Market Research, the global mass spectrometry ...
Breaking Medicine Technology: